Vicki Brower. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useCarcinoma, Hepatocellular/drug therapyCarcinoma, Hepatocellular/mortalityCarcinoma, Hepatocellular/pathologyCisplatin/administration & dosageCisplatin/adverse effectsClinical Trials, Phase II as TopicDisease ProgressionHumansLiver Neoplasms/drug therapyLiver Neoplasms/mortalityLiver Neoplasms/pathologyNiacinamide/administration & dosageNiacinamide/adverse effectsNiacinamide/analogs & derivativesPhenylurea Compounds/administration & dosagePhenylurea Compounds/adverse effectsRandomized Controlled Trials as TopicSorafenibTreatment Outcome
Substances: See more » Phenylurea CompoundsNiacinamideSorafenibCisplatin
Year: 2016 PMID: 27617663 DOI: 10.1016/S1470-2045(16)30447-8
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316